Correlation Between Silo Pharma and Champions Oncology

Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Silo Pharma and Champions Oncology, you can compare the effects of market volatilities on Silo Pharma and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Champions Oncology.

Diversification Opportunities for Silo Pharma and Champions Oncology

0.67

Correlation Coefficient

Silo Pharma  Champions Oncology

Poor diversification

The 3 months correlation between Silo and Champions is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Silo Pharma i.e., Silo Pharma and Champions Oncology go up and down completely randomly.

Pair Corralation between Silo Pharma and Champions Oncology

Given the investment horizon of 90 days Silo Pharma is expected to generate 1.58 times more return on investment than Champions Oncology. However, Silo Pharma is 1.58 times more volatile than Champions Oncology. It trades about 0.1 of its potential returns per unit of risk. Champions Oncology is currently generating about 0.04 per unit of risk. If you would invest  89.00  in Silo Pharma on December 29, 2024 and sell it today you would earn a total of  36.00  from holding Silo Pharma or generate 40.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Silo Pharma  vs.  Champions Oncology

Silo Pharma

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Silo Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal essential indicators, Silo Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Champions Oncology

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental drivers, Champions Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Silo Pharma and Champions Oncology

The main advantage of trading using opposite Silo Pharma and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.

The idea behind Silo Pharma and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.